TY - JOUR
T1 - Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjects
AU - Tamura, Naohiko
AU - Agrawal, Devendra K.
AU - Suliaman, Fawzi A.
AU - Townley, Robert G.
N1 - Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.
PY - 1987/2/13
Y1 - 1987/2/13
N2 - Highly purified eosinophils were obtained from normal subjects, and their chemotactic responses to platelet activating factor (PAF) were evaluated. PAF induced both eosinophil chemotactic and chemokinetic responses, and was 100 fold more potent eosinophil chemotactic factor as compared to eosinophil chemotactic factor of anaphylaxis. On the other hand, leukotriene B4 did not show any eosinophil chemotactic activity. A selective PAF antagonist, BN52021, inhibited eosinophil chemotaxis in a dose dependent manner. Preincubation of eosinophils with PAF induced the deactivation of eosinophils for further chemotactic responses to PAF. These findings suggest that PAF is a potent chemotactic factor for normal eosinophils.
AB - Highly purified eosinophils were obtained from normal subjects, and their chemotactic responses to platelet activating factor (PAF) were evaluated. PAF induced both eosinophil chemotactic and chemokinetic responses, and was 100 fold more potent eosinophil chemotactic factor as compared to eosinophil chemotactic factor of anaphylaxis. On the other hand, leukotriene B4 did not show any eosinophil chemotactic activity. A selective PAF antagonist, BN52021, inhibited eosinophil chemotaxis in a dose dependent manner. Preincubation of eosinophils with PAF induced the deactivation of eosinophils for further chemotactic responses to PAF. These findings suggest that PAF is a potent chemotactic factor for normal eosinophils.
UR - http://www.scopus.com/inward/record.url?scp=0023151694&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023151694&partnerID=8YFLogxK
U2 - 10.1016/0006-291X(87)91462-8
DO - 10.1016/0006-291X(87)91462-8
M3 - Article
C2 - 3030295
AN - SCOPUS:0023151694
SN - 0006-291X
VL - 142
SP - 638
EP - 644
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 3
ER -